Skip to content

BBNX BBNX Current ratio

Current ratio at other companies

Insulet logo
InsuletPODD
2.5×-2.0×
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
3.6×+1.3×
Medtronic logo
MedtronicMDT
2.1×+0.3×
AdaptHealth logo
AdaptHealthAHCO
0.9×-0.4×
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
2.8×-5.6×

Other financials

Income statement

See full
Revenue$27.6M+56.6%
Gross profit$16.4M+83.2%
Operating income-$24.3M-30.2%
Net income-$21.9M+23.6%
EPS (diluted)-$0.49+47.3%

Balance sheet

See full
Cash & equivalents$30.2M-28.9%
Total debt$6.9M-0.9%
Total equity$271.2M-13.5%
Total assets$304.4M-9.9%

Cash flow

See full
Operating cash flow-$23.8M-19.3%
CapEx$1.4M+314%
Free cash flow-$25.2M-24.1%

Valuation

See full
Market cap$708.98M-8.6%
Enterprise value$685.68M
P/S6.4×

Profitability

See full
Gross margin57.2%+3.2pp
Operating margin-70.1%-6.4pp
Net margin-60.3%-17.4pp
FCF margin-55.4%-14.3pp

Returns & leverage

See full
Return on equity-22.7%
Debt / equity0.0×

Where this comes from

Calculated from BBNX’s reported figures.

Based on the most recent quarter.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BBNX's current ratio?
BBNX (BBNX) reported current ratio of 10.7× in Q1 2026.
How has BBNX's current ratio changed year-over-year?
BBNX's current ratio decreased by 32.7% year-over-year, from 15.9× to 10.7×.
What is the long-term trend for BBNX's current ratio?
Over 2 years (2023 to 2025), BBNX's current ratio has grown at a -5.8% compound annual growth rate (CAGR), from 9.8× to 8.7×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.